Promptly Health, an emerging provider of European real-world data access, and Datavant, the leader in securely connecting health data, have announced a collaboration to address the challenges of a fragmented health data landscape in Europe.The healthcare ecosystem presents challenges to effective data sharing, with organisations seeking simpler methods collaboration, but their data is often scattered across various healthcare contexts and databases.The European Health Data Space, provisionally approved on 15 March 2024, aims to address these issues.

欧洲现实世界数据访问的新兴提供商迅捷健康（Emply Health）和安全连接健康数据的领导者Datavant宣布进行合作，以应对欧洲零散健康数据格局的挑战。医疗保健生态系统对有效的数据共享提出了挑战，组织寻求更简单的方法协作，但他们的数据通常分散在各种医疗保健环境和数据库中。2024年3月15日临时批准的欧洲健康数据空间旨在解决这些问题。

This new EU regulation aims to empower individuals to control their health data, support the use of health data to improve health delivery, research, innovation and policy making, and enables the EU to fully utilise the potential of safe and secure health data exchange.Promptly Health and Datavant will combine their strengths in data federation, harmonisation and tokenisation to enhance patient data utilisation in Europe and prepare the ecosystem for the future European Health Data Space.The partnership will utilise Datavant’s technology, which enables the matching of de-identified patient records, and Promptly’s secure data access capabilities to transform routine medical data trapped across silos into research-grade data assets.The two companies will provide health data stakeholders such as hospitals, biopharmaceutical companies, health insurers, regulators, and policymakers, visibility into patient populations to expand value-based care initiatives, improve risk predictability and clinical decision-making, and close care gaps.

这项新的欧盟法规旨在授权个人控制其健康数据，支持使用健康数据来改善健康服务，研究，创新和政策制定，并使欧盟能够充分利用安全可靠的健康数据交换的潜力。迅捷健康和Datavant将结合其在数据联合、协调和标记化方面的优势，以提高欧洲患者数据的利用率，并为未来的欧洲健康数据空间准备生态系统。该合作伙伴关系将利用Datavant的技术，该技术能够匹配未识别的患者记录，并迅速利用其安全的数据访问能力，将孤立的常规医疗数据转换为研究级数据资产。这两家公司将为医院、生物制药公司、健康保险公司、监管机构和政策制定者等健康数据利益相关者提供对患者人群的可见性，以扩大基于价值的护理计划，提高风险可预测性和临床决策，并弥合护理差距。

It will also generate opportunities for closer connectivity to clinical trials and life sciences projects.Pedro Ramos, CEO at Promptly Health, said: “The combination of Promptly’s real-world data ca.

它还将为与临床试验和生命科学项目建立更紧密的联系创造机会。迅捷健康公司首席执行官佩德罗·拉莫斯（PedroRamos）说：“迅捷公司的真实数据结合在一起。